8-KEarnings & ResultsExhibits & Filings

PFIZER INC 8-K Report, Financial Results (Jan 30, 2018)

Filed January 30, 2018For Securities:PFE

Summary

Pfizer Inc. (PFE) filed an 8-K report on January 30, 2018, to announce its fourth-quarter and full-year 2017 financial results. The report itself is brief, primarily furnishing a press release (Exhibit 99) that contains the detailed financial performance data for the periods ending December 31, 2017. Investors should refer to the press release for specific figures regarding revenue, earnings, and operational performance. This filing serves as the official notification of Pfizer's latest financial outcomes. While the 8-K itself doesn't contain extensive analysis, it directs investors to the comprehensive press release. Key information for shareholders will include year-over-year comparisons, guidance for the upcoming year (if provided in the press release), and any significant business updates or strategic mentions made by the company concerning its performance and outlook.

Key Highlights

  • 1Pfizer announced its Q4 and Full-Year 2017 financial results on January 30, 2018.
  • 2The 8-K filing incorporates by reference a press release (Exhibit 99) containing the detailed financial results.
  • 3Investors should consult the furnished press release for specific financial performance data, including revenue and earnings.
  • 4The filing is dated January 29, 2018, with the announcement made on January 30, 2018.
  • 5This report is a standard disclosure for earnings announcements and directs stakeholders to the official press release for comprehensive details.

Frequently Asked Questions

The main purpose of this 8-K filing is to officially announce and provide access to Pfizer's financial results for the fourth quarter and the full year of 2017 through an attached press release.

The specific financial details are contained within the press release furnished as Exhibit 99 to this 8-K filing. You should refer to that press release for comprehensive data.

This 8-K filing itself does not contain detailed forward-looking statements or guidance. Such information would typically be found in the press release (Exhibit 99) referenced in the filing.

No, the information furnished under Item 2.02 of this 8-K, including the press release, is not deemed 'filed' for purposes of Section 18 of the Exchange Act, nor is it subject to the liabilities of that section, unless expressly incorporated by reference into another filing.